drugset / Trial / NCT01841411

Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis

NCT01841411

Phase 4 Unknown 90 enrolled Minia University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

N-Acetyl cysteine (NAC) is an amino acid with strong antioxidant, mucolytic and antibacterial properties, and is produced within the human body.Its effect in biofilms has been tested in several bacteria. Biofilms have recently been observed in 90% of subjects with bacterial vaginosis (BV) with Gardnerella vaginalis being the predominant species. Although a wide range of antimicrobial agents are currently available, treatment options for controlling BV are still limited. Furthermore, the number of relapses are increasing and require alternative treatments. This study is aiming to evaluate the role of NAC in treatment of BV and prevention of recurrence.

Timeline

Start
2013-03
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule 500 mg Oral
Subject N-acetylcysteine Small molecule 200 mg Other

Indications